Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorized mRNA-based shot for the condition.
Canada approves Moderna's RSV vaccine for those age 60 and older, company says
Post a Comment